{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:31:35Z","timestamp":1793039495262,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100017804","name":"City of Hope","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017804","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Opinion Statement<\/jats:title>\n          <jats:p>Ovarian cancer, particularly high-grade serous carcinoma (HGSC), remains a leading cause of mortality in gynecologic oncology. Emerging research identifies serous tubal intraepithelial carcinoma (STIC) as a precursor lesion in many HGSC cases, highlighting its role in ovarian cancer pathogenesis and prevention. Management of STIC is challenging, as there is only limited data available to guide clinical decision-making.\u00a0For average-risk women, opportunistic salpingectomy is increasingly being adopted during routine procedures such as hysterectomy or cesarean section. This intervention has demonstrated significant potential in reducing ovarian cancer incidence while maintaining safety and feasibility.\u00a0For high-risk individuals, particularly BRCA mutation carriers, risk-reducing salpingo-oophorectomy (RRSO) remains the gold standard. RRSO significantly lowers ovarian cancer risk, though alternative approaches like salpingectomy alone or radical fimbriectomy are under investigation to preserve ovarian function in younger patients. To improve STIC detection, SEE-FIM pathology protocol is recommended when patients are undergoing risk-reducing surgery to prevent ovarian cancer, but challenges such as diagnostic variability and limited data persist.\u00a0When STIC is detected incidentally, management varies based on risk factors and lesion characteristics. Genetic counseling and testing are essential when STIC is identified, as hereditary predisposition may guide further management. Surgical management is advised for cases of STIC with microinvasive carcinoma, but routine use of surgical management for STIC is not clearly defined in the literature. Bilateral oophorectomy is generally recommended when STIC is identified, and adnexal structures have not yet been removed. Chemotherapy is not recommended for treatment of STIC. Surveillance is suggested when STIC has been diagnosed, but there are no set guidelines as to the frequency and type of monitoring.\u00a0Future directions include refining molecular profiling to predict progression and conducting randomized studies to establish evidence-based guidelines. Multidisciplinary collaboration is essential to optimize prevention and treatment, ultimately reducing HGSC incidence and improving patient outcomes.<\/jats:p>","DOI":"10.1007\/s11864-025-01346-0","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T11:18:41Z","timestamp":1757071121000},"page":"910-919","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["From Fallopian Tube to Ovarian Cancer: Understanding the Evaluation and Management of Serous Tubal Intraepithelial Carcinoma Lesions"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2837-842X","authenticated-orcid":false,"given":"Vinita","family":"Popat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6224-8544","authenticated-orcid":false,"given":"Ernest","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,5]]},"reference":[{"issue":"6","key":"1346_CR1","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","volume":"49","author":"J Ferlay","year":"2013","unstructured":"Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374\u2013403. https:\/\/doi.org\/10.1016\/j.ejca.2012.12.027.","journal-title":"Eur J Cancer"},{"key":"1346_CR2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21871","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025. https:\/\/doi.org\/10.3322\/caac.21871.","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"1346_CR3","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1038\/bjc.2011.455","volume":"105","author":"EI Braicu","year":"2011","unstructured":"Braicu EI, Sehouli J, Richter R, Pietzner K, Denkert C, Fotopoulou C. Role of histological type on surgical outcome and survival following radical primary tumour debulking of epithelial ovarian, fallopian tube and peritoneal cancers. Br J Cancer. 2011;105(12):1818\u201324. https:\/\/doi.org\/10.1038\/bjc.2011.455.","journal-title":"Br J Cancer"},{"issue":"3","key":"1346_CR4","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/AOG.0000000000000981","volume":"126","author":"RD Cress","year":"2015","unstructured":"Cress RD, Chen YS, Morris CR, Petersen M, Leiserowitz GS. Characteristics of long-term survivors of epithelial ovarian cancer. Obstet Gynecol. 2015;126(3):491\u20137. https:\/\/doi.org\/10.1097\/AOG.0000000000000981.","journal-title":"Obstet Gynecol"},{"key":"1346_CR5","doi-asserted-by":"crossref","unstructured":"Henderson JT, Webber EM, Sawaya GF. Screening for ovarian cancer: an updated evidence review for the US preventive services task force. U.S. preventive services task force.evidence syntheses, formerly systematic evidence reviews. Rockville (MD) 2018.","DOI":"10.1001\/jama.2017.21421"},{"issue":"10290","key":"1346_CR6","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1016\/S0140-6736(21)00731-5","volume":"397","author":"U Menon","year":"2021","unstructured":"Menon U, Gentry-Maharaj A, Burnell M, Singh N, Ryan A, Karpinskyj C, et al. Ovarian cancer population screening and mortality after long-term follow-up in the UK collaborative trial of ovarian cancer screening (UKCTOCS): a randomised controlled trial. Lancet. 2021;397(10290):2182\u201393. https:\/\/doi.org\/10.1016\/S0140-6736(21)00731-5.","journal-title":"Lancet"},{"issue":"2","key":"1346_CR7","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.molonc.2009.02.001","volume":"3","author":"SJ Ramus","year":"2009","unstructured":"Ramus SJ, Gayther SA. The contribution of BRCA1 and BRCA2 to ovarian cancer. Mol Oncol. 2009;3(2):138\u201350. https:\/\/doi.org\/10.1016\/j.molonc.2009.02.001.","journal-title":"Mol Oncol"},{"issue":"3","key":"1346_CR8","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1097\/AOG.0000000000002285","volume":"130","author":"Practice Bulletin No","year":"2017","unstructured":"Practice Bulletin No. 182 summary: hereditary breast and ovarian Cancer syndrome. Obstet Gynecol. 2017;130(3):657\u20139. https:\/\/doi.org\/10.1097\/AOG.0000000000002285.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"1346_CR9","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/PGP.0000000000000123","volume":"34","author":"JD Seidman","year":"2015","unstructured":"Seidman JD. Serous tubal intraepithelial carcinoma localizes to the tubal-peritoneal junction: a pivotal clue to the site of origin of extrauterine high-grade serous carcinoma (ovarian cancer). Int J Gynecol Pathol. 2015;34(2):112\u201320. https:\/\/doi.org\/10.1097\/PGP.0000000000000123.","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"1346_CR10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/PGP.0b013e3181f29d2a","volume":"30","author":"JD Seidman","year":"2011","unstructured":"Seidman JD, Yemelyanova A, Zaino RJ, Kurman RJ. The fallopian tube-peritoneal junction: a potential site of carcinogenesis. Int J Gynecol Pathol. 2011;30(1):4\u201311. https:\/\/doi.org\/10.1097\/PGP.0b013e3181f29d2a.","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"1346_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ajpath.2020.09.006","volume":"191","author":"IM Shih","year":"2021","unstructured":"Shih IM, Wang Y, Wang TL. The origin of ovarian cancer species and precancerous landscape. Am J Pathol. 2021;191(1):26\u201339. https:\/\/doi.org\/10.1016\/j.ajpath.2020.09.006.","journal-title":"Am J Pathol"},{"issue":"10","key":"1346_CR12","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1097\/PAS.0b013e3181ef7b16","volume":"34","author":"CG Przybycin","year":"2010","unstructured":"Przybycin CG, Kurman RJ, Ronnett BM, Shih Ie M, Vang R. Are all pelvic (nonuterine) serous carcinomas of tubal origin? Am J Surg Pathol. 2010;34(10):1407\u201316. https:\/\/doi.org\/10.1097\/PAS.0b013e3181ef7b16.","journal-title":"Am J Surg Pathol"},{"key":"1346_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10110433","author":"J Kim","year":"2018","unstructured":"Kim J, Park EY, Kim O, Schilder JM, Coffey DM, Cho CH, et al. Cell origins of high-grade serous ovarian cancer. Cancers (Basel). 2018. https:\/\/doi.org\/10.3390\/cancers10110433.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"1346_CR14","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1097\/AOG.0000000000005297","volume":"142","author":"Management of Endometrial Intraepithelial Neoplasia or Atypical Endometrial Hyperplasia","year":"2023","unstructured":"Management of Endometrial Intraepithelial Neoplasia or Atypical Endometrial Hyperplasia. ACOG clinical consensus 5. Obstet Gynecol. 2023;142(3):735\u201344. https:\/\/doi.org\/10.1097\/AOG.0000000000005297.","journal-title":"Obstet Gynecol"},{"issue":"13","key":"1346_CR15","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1111\/1471-0528.17919","volume":"131","author":"S Negri","year":"2024","unstructured":"Negri S, Fisch C, de Hullu JA, van Bommel M, Simons M, Bogaerts J, et al. Diagnosis and management of isolated serous tubal intraepithelial carcinoma: a qualitative focus group study. BJOG. 2024;131(13):1851\u201361. https:\/\/doi.org\/10.1111\/1471-0528.17919.","journal-title":"BJOG"},{"issue":"11","key":"1346_CR16","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1158\/1940-6207.CAPR-18-0009","volume":"11","author":"K Visvanathan","year":"2018","unstructured":"Visvanathan K, Shaw P, May BJ, Bahadirli-Talbott A, Kaushiva A, Risch H, et al. Fallopian tube lesions in women at high risk for ovarian cancer: A multicenter study. Cancer Prev Res (Phila). 2018;11(11):697\u2013706. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-18-0009.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"11","key":"1346_CR17","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.jogc.2022.08.018","volume":"44","author":"J Ruel-Laliberte","year":"2022","unstructured":"Ruel-Laliberte J, Kasasni SM, Oprea D, Viau M. Outcome and management of serous tubal intraepithelial carcinoma following opportunistic salpingectomy: systematic review and meta-analysis. J Obstet Gynaecol Can. 2022;44(11):1174\u201380. https:\/\/doi.org\/10.1016\/j.jogc.2022.08.018.","journal-title":"J Obstet Gynaecol Can"},{"issue":"17","key":"1346_CR18","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1200\/JCO.21.02016","volume":"40","author":"MP Steenbeek","year":"2022","unstructured":"Steenbeek MP, van Bommel MHD, Bulten J, Hulsmann JA, Bogaerts J, Garcia C, et al. Risk of peritoneal carcinomatosis after risk-reducing salpingo-oophorectomy: a systematic review and individual patient data meta-analysis. J Clin Oncol. 2022;40(17):1879\u201391. https:\/\/doi.org\/10.1200\/JCO.21.02016.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1346_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pky061","volume":"2","author":"G Samimi","year":"2018","unstructured":"Samimi G, Trabert B, Geczik AM, Duggan MA, Sherman ME. Population frequency of serous tubal intraepithelial carcinoma (STIC) in clinical practice using see-fim protocol. JNCI Cancer Spectr. 2018;2(4): pky061. https:\/\/doi.org\/10.1093\/jncics\/pky061.","journal-title":"JNCI Cancer Spectr"},{"issue":"1","key":"1346_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-019-0525-1","volume":"12","author":"PI Stanciu","year":"2019","unstructured":"Stanciu PI, Ind TEJ, Barton DPJ, Butler JB, Vroobel KM, Attygalle AD, et al. Development of peritoneal carcinoma in women diagnosed with serous tubal intraepithelial carcinoma (STIC) following risk-reducing salpingo-oophorectomy (RRSO). J Ovarian Res. 2019;12(1): 50. https:\/\/doi.org\/10.1186\/s13048-019-0525-1.","journal-title":"J Ovarian Res"},{"issue":"2","key":"1346_CR21","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.ygyno.2021.02.006","volume":"161","author":"R Cowan","year":"2021","unstructured":"Cowan R, Nobre SP, Pradhan N, Yasukawa M, Zhou QC, Iasonos A, et al. Outcomes of incidentally detected ovarian cancers diagnosed at time of risk-reducing salpingo-oophorectomy in BRCA mutation carriers. Gynecol Oncol. 2021;161(2):521\u20136. https:\/\/doi.org\/10.1016\/j.ygyno.2021.02.006.","journal-title":"Gynecol Oncol"},{"issue":"11","key":"1346_CR22","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1093\/carcin\/bgv132","volume":"36","author":"HS Huang","year":"2015","unstructured":"Huang HS, Chu SC, Hsu CF, Chen PC, Ding DC, Chang MY, et al. Mutagenic, surviving and tumorigenic effects of follicular fluid in the context of p53 loss: initiation of fimbria carcinogenesis. Carcinogenesis. 2015;36(11):1419\u201328. https:\/\/doi.org\/10.1093\/carcin\/bgv132.","journal-title":"Carcinogenesis"},{"key":"1346_CR23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ygyno.2024.05.010","volume":"187","author":"CB van den Berg","year":"2024","unstructured":"van den Berg CB, Dasgupta S, Ewing-Graham PC, Bart J, Bulten J, Gaarenstroom KN, et al. Does serous tubal intraepithelial carcinoma (STIC) metastasize? The clonal relationship between STIC and subsequent high-grade serous carcinoma in BRCA1\/2 mutation carriers several years after risk-reducing salpingo-oophorectomy. Gynecol Oncol. 2024;187:113\u20139. https:\/\/doi.org\/10.1016\/j.ygyno.2024.05.010.","journal-title":"Gynecol Oncol"},{"issue":"12","key":"1346_CR24","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1097\/PAS.0b013e31822f58bc","volume":"35","author":"K Visvanathan","year":"2011","unstructured":"Visvanathan K, Vang R, Shaw P, Gross A, Soslow R, Parkash V, et al. Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: a reproducibility study. Am J Surg Pathol. 2011;35(12):1766\u201375. https:\/\/doi.org\/10.1097\/PAS.0b013e31822f58bc.","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"1346_CR25","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/PGP.0b013e31823b8831","volume":"31","author":"R Vang","year":"2012","unstructured":"Vang R, Visvanathan K, Gross A, Maambo E, Gupta M, Kuhn E, et al. Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinoma. Int J Gynecol Pathol. 2012;31(3):243\u201353. https:\/\/doi.org\/10.1097\/PGP.0b013e31823b8831.","journal-title":"Int J Gynecol Pathol"},{"issue":"6","key":"1346_CR26","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1097\/PAS.0000000000000199","volume":"38","author":"JT Rabban","year":"2014","unstructured":"Rabban JT, Garg K, Crawford B, Chen LM, Zaloudek CJ. Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during benign surgery. Am J Surg Pathol. 2014;38(6):729\u201342. https:\/\/doi.org\/10.1097\/PAS.0000000000000199.","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"1346_CR27","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.annonc.2023.11.015","volume":"35","author":"JA Ledermann","year":"2024","unstructured":"Ledermann JA, Matias-Guiu X, Amant F, Concin N, Davidson B, Fotopoulou C, et al. ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease. Ann Oncol. 2024;35(3):248\u201366. https:\/\/doi.org\/10.1016\/j.annonc.2023.11.015.","journal-title":"Ann Oncol"},{"key":"1346_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2021.100795","volume":"37","author":"N Badiner","year":"2021","unstructured":"Badiner N, Nchako CM, Ma L, Frey MK. Ovarian cancer arising from the proximal fallopian tube in a patient with a BRCA2 mutation. Gynecol Oncol Rep. 2021;37: 100795. https:\/\/doi.org\/10.1016\/j.gore.2021.100795.","journal-title":"Gynecol Oncol Rep"},{"issue":"4","key":"1346_CR29","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/PGP.0b013e3181c713a8","volume":"29","author":"JW Carlson","year":"2010","unstructured":"Carlson JW, Jarboe EA, Kindelberger D, Nucci MR, Hirsch MS, Crum CP. Serous tubal intraepithelial carcinoma: diagnostic reproducibility and its implications. Int J Gynecol Pathol. 2010;29(4):310\u20134. https:\/\/doi.org\/10.1097\/PGP.0b013e3181c713a8.","journal-title":"Int J Gynecol Pathol"},{"issue":"4","key":"1346_CR30","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s00428-021-03244-w","volume":"480","author":"JMA Bogaerts","year":"2022","unstructured":"Bogaerts JMA, Steenbeek MP, van Bommel MHD, Bulten J, van der Laak J, de Hullu JA, et al. Recommendations for diagnosing STIC: a systematic review and meta-analysis. Virchows Arch. 2022;480(4):725\u201337. https:\/\/doi.org\/10.1007\/s00428-021-03244-w.","journal-title":"Virchows Arch"},{"issue":"4","key":"1346_CR31","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/PAS.0000000000002187","volume":"48","author":"YW Chien","year":"2024","unstructured":"Chien YW, Wang Y, Huang P, Lawson BC, Kolin DL, Chui MH, et al. Morphologic and molecular heterogeneity of high-grade serous carcinoma precursor lesions. Am J Surg Pathol. 2024;48(4):475\u201386. https:\/\/doi.org\/10.1097\/PAS.0000000000002187.","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"1346_CR32","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jmig.2016.12.007","volume":"24","author":"C Corzo","year":"2017","unstructured":"Corzo C, Iniesta MD, Patrono MG, Lu KH, Ramirez PT. Role of fallopian tubes in the development of ovarian cancer. J Minim Invasive Gynecol. 2017;24(2):230\u20134. https:\/\/doi.org\/10.1016\/j.jmig.2016.12.007.","journal-title":"J Minim Invasive Gynecol"},{"issue":"11","key":"1346_CR33","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1001\/jamasurg.2023.4164","volume":"158","author":"RM Kahn","year":"2023","unstructured":"Kahn RM, Gordhandas S, Godwin K, Stone RL, Worley MJ Jr., Lu KH, et al. Salpingectomy for the primary prevention of ovarian cancer: a systematic review. JAMA Surg. 2023;158(11):1204\u201311. https:\/\/doi.org\/10.1001\/jamasurg.2023.4164.","journal-title":"JAMA Surg"},{"issue":"2","key":"1346_CR34","doi-asserted-by":"publisher","first-page":"e2147343","DOI":"10.1001\/jamanetworkopen.2021.47343","volume":"5","author":"GE Hanley","year":"2022","unstructured":"Hanley GE, Pearce CL, Talhouk A, Kwon JS, Finlayson SJ, McAlpine JN, et al. Outcomes from opportunistic salpingectomy for ovarian cancer prevention. JAMA Netw Open. 2022;5(2):e2147343. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.47343.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"1346_CR35","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ygyno.2014.10.005","volume":"135","author":"CR Lessard-Anderson","year":"2014","unstructured":"Lessard-Anderson CR, Handlogten KS, Molitor RJ, Dowdy SC, Cliby WA, Weaver AL, et al. Effect of tubal sterilization technique on risk of serous epithelial ovarian and primary peritoneal carcinoma. Gynecol Oncol. 2014;135(3):423\u20137. https:\/\/doi.org\/10.1016\/j.ygyno.2014.10.005.","journal-title":"Gynecol Oncol"},{"issue":"10","key":"1346_CR36","doi-asserted-by":"publisher","first-page":"6953","DOI":"10.1007\/s00432-023-04578-5","volume":"149","author":"IB Runnebaum","year":"2023","unstructured":"Runnebaum IB, Kather A, Vorwergk J, Cruz JJ, Mothes AR, Beteta CR, et al. Ovarian cancer prevention by opportunistic salpingectomy is a new de facto standard in Germany. J Cancer Res Clin Oncol. 2023;149(10):6953\u201366. https:\/\/doi.org\/10.1007\/s00432-023-04578-5.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"1346_CR37","doi-asserted-by":"publisher","first-page":"E279","DOI":"10.1097\/Aog.0000000000003164","volume":"133","author":"L Chohan","year":"2019","unstructured":"Chohan L, Richardson DL, Practice CG. Opportunistic salpingectomy as a strategy for epithelial ovarian Cancer prevention. Obstet Gynecol. 2019;133(4):E279\u201384. https:\/\/doi.org\/10.1097\/Aog.0000000000003164.","journal-title":"Obstet Gynecol"},{"key":"1346_CR38","unstructured":"SGO Clinical Practice Statement. Salpingectomy for Ovarian Cancer Prevention. In: SGO, editor. sgo.org2013."},{"key":"1346_CR39","doi-asserted-by":"publisher","unstructured":"Hanley GE, McAlpine JN, Pearce CL, Miller D. The performance and safety of bilateral salpingectomy for ovarian cancer prevention in the United States. Am J Obstet Gynecol. 2017;216(3):270 e1- e9. https:\/\/doi.org\/10.1016\/j.ajog.2016.10.035","DOI":"10.1016\/j.ajog.2016.10.035"},{"issue":"4","key":"1346_CR40","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1097\/AOG.0b013e3182864350","volume":"121","author":"WH Parker","year":"2013","unstructured":"Parker WH, Feskanich D, Broder MS, Chang E, Shoupe D, Farquhar CM, et al. Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses\u2019 health study. Obstet Gynecol. 2013;121(4):709\u201316. https:\/\/doi.org\/10.1097\/AOG.0b013e3182864350.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"1346_CR41","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2017.28.e3","volume":"28","author":"YJ Lee","year":"2017","unstructured":"Lee YJ, Lee SW, Kim KR, Jung KH, Lee JW, Kim YM. Pathologic findings at risk-reducing salpingo-oophorectomy (RRSO) in germline BRCA mutation carriers with breast cancer: significance of bilateral RRSO at the optimal age in germline BRCA mutation carriers. J Gynecol Oncol. 2017;28(1): e3. https:\/\/doi.org\/10.3802\/jgo.2017.28.e3.","journal-title":"J Gynecol Oncol"},{"key":"1346_CR42","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ygyno.2023.04.006","volume":"173","author":"L Perez","year":"2023","unstructured":"Perez L, Webster E, Bull L, Brewer JT, Ahsan MD, Lin J, et al. Patient perspectives on risk-reducing salpingectomy with delayed oophorectomy for ovarian cancer risk-reduction: a systematic review of the literature. Gynecol Oncol. 2023;173:106\u201313. https:\/\/doi.org\/10.1016\/j.ygyno.2023.04.006.","journal-title":"Gynecol Oncol"},{"key":"1346_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15041141","author":"E Leblanc","year":"2023","unstructured":"Leblanc E, Narducci F, Ferron G, Mailliez A, Charvolin JY, Houssein EH, et al. Prophylactic radical fimbriectomy with delayed oophorectomy in women with a high risk of developing an ovarian carcinoma: results of a prospective national pilot study. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15041141.","journal-title":"Cancers (Basel)"},{"key":"1346_CR44","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.TPS10615","author":"WK Huh","year":"2022","unstructured":"Huh WK, Pugh SL, Walker JL, Pennington K, Jewell EL, Havrilesky LJ, et al. NRG-CC008: a nonrandomized prospective clinical trial comparing the non-inferiority of salpingectomy to salpingo-oophorectomy to reduce the risk of ovarian cancer among BRCA1 carriers [SOROCk]. J Clin Oncol. 2022. https:\/\/doi.org\/10.1200\/JCO.2022.40.16_suppl.TPS10615","journal-title":"J Clin Oncol"},{"issue":"7","key":"1346_CR45","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1111\/j.1471-0528.2011.02920.x","volume":"118","author":"R Manchanda","year":"2011","unstructured":"Manchanda R, Abdelraheim A, Johnson M, Rosenthal AN, Benjamin E, Brunell C, et al. Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status. BJOG. 2011;118(7):814\u201324. https:\/\/doi.org\/10.1111\/j.1471-0528.2011.02920.x.","journal-title":"BJOG"},{"key":"1346_CR46","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1016\/j.ygyno.2024.07.068","volume":"190","author":"S Sha","year":"2024","unstructured":"Sha S, Wilkinson-Ryan I, Bentz J, Cass I. STIC to it: the incidental finding of serous tubal intraepithelial carcinoma requires further testing. Gynecol Oncol. 2024;190:S42\u20133.","journal-title":"Gynecol Oncol"},{"issue":"9","key":"1346_CR47","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1055\/a-1395-7715","volume":"81","author":"T Pross","year":"2021","unstructured":"Pross T, Karsten MM, Blohmer JU, Speiser D. Role of routine peritoneal biopsies during risk reducing salpingo-oophorectomy (RRSO). Geburtshilfe Frauenheilkd. 2021;81(9):1031\u20138. https:\/\/doi.org\/10.1055\/a-1395-7715.","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"5","key":"1346_CR48","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.jmig.2017.03.001","volume":"24","author":"H Miller","year":"2017","unstructured":"Miller H, Pipkin LS, Tung C, Hall TR, Masand RP, Anderson ML. The role of routine peritoneal and omental biopsies at risk-reducing salpingo-oophorectomy. J Minim Invasive Gynecol. 2017;24(5):772\u20136. https:\/\/doi.org\/10.1016\/j.jmig.2017.03.001.","journal-title":"J Minim Invasive Gynecol"},{"key":"1346_CR49","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12885-015-2011-5","volume":"16","author":"F Blok","year":"2016","unstructured":"Blok F, Roes EM, van Leenders GJ, van Beekhuizen HJ. The lack of clinical value of peritoneal washing cytology in high risk patients undergoing risk-reducing salpingo-oophorectomy: a retrospective study and review. BMC Cancer. 2016;16:18. https:\/\/doi.org\/10.1186\/s12885-015-2011-5.","journal-title":"BMC Cancer"},{"issue":"1","key":"1346_CR50","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ygyno.2012.08.019","volume":"128","author":"K Haldar","year":"2013","unstructured":"Haldar K, Crawford R. The role of peritoneal cytology at risk-reducing salpingo-oophorectomy (RRSO) in women at increased risk of familial ovarian\/tubal cancer: is the evidence strong enough? Gynecol Oncol. 2013;128(1):148\u20139. https:\/\/doi.org\/10.1016\/j.ygyno.2012.08.019.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"1346_CR51","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ygyno.2012.09.031","volume":"128","author":"R Manchanda","year":"2013","unstructured":"Manchanda R, Drapkin R, Menon U. There is a need for routine peritoneal cytology at RRSO. Gynecol Oncol. 2013;128(1):149\u201350. https:\/\/doi.org\/10.1016\/j.ygyno.2012.09.031.","journal-title":"Gynecol Oncol"},{"issue":"8","key":"1346_CR52","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.clon.2018.03.036","volume":"30","author":"NMA Van der Hoeven","year":"2018","unstructured":"Van der Hoeven NMA, Van Wijk K, Bonfrer SE, Beltman JJ, Louwe LA, De Kroon CD, et al. Outcome and prognostic impact of surgical staging in serous tubal intraepithelial carcinoma: a cohort study and systematic review. Clin Oncol (R Coll Radiol). 2018;30(8):463\u201371. https:\/\/doi.org\/10.1016\/j.clon.2018.03.036.","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"9","key":"1346_CR53","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1097\/IGC.0b013e3182a80ac8","volume":"23","author":"SL Wethington","year":"2013","unstructured":"Wethington SL, Park KJ, Soslow RA, Kauff ND, Brown CL, Dao F, et al. Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC). Int J Gynecol Cancer. 2013;23(9):1603\u201311. https:\/\/doi.org\/10.1097\/IGC.0b013e3182a80ac8.","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"1346_CR54","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ygyno.2013.01.029","volume":"129","author":"CB Powell","year":"2013","unstructured":"Powell CB, Swisher EM, Cass I, McLennan J, Norquist B, Garcia RL, et al. Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy. Gynecol Oncol. 2013;129(2):364\u201371. https:\/\/doi.org\/10.1016\/j.ygyno.2013.01.029.","journal-title":"Gynecol Oncol"},{"issue":"12","key":"1346_CR55","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1080\/14737140.2016.1247699","volume":"16","author":"V Weinberger","year":"2016","unstructured":"Weinberger V, Bednarikova M, Cibula D, Zikan M. Serous tubal intraepithelial carcinoma (STIC) - clinical impact and management. Expert Rev Anticancer Ther. 2016;16(12):1311\u201321. https:\/\/doi.org\/10.1080\/14737140.2016.1247699.","journal-title":"Expert Rev Anticancer Ther"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-025-01346-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11864-025-01346-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-025-01346-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T07:35:34Z","timestamp":1759995334000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11864-025-01346-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,5]]},"references-count":55,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1346"],"URL":"https:\/\/doi.org\/10.1007\/s11864-025-01346-0","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,5]]},"assertion":[{"value":"21 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}